The ethics of placebo-controlled trials in developing countries to prevent mother-to-child transmission of HIV
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jack Alan Reynolds
Learn more about PhilPapers
Annals, Academy of Medicine, Singapore 29 (5):557-562 (2000)
Placebo-trials on HIV-infected pregnant women in developing countries like Thailand and Uganda have provoked recent controversy. Such experiments aim to find a treatment that will cut the rate of vertical transmission more efficiently than existing treatments like zidovudine. This scenario is first stated as generally as possible, before three ethical principles found in the Belmont Report, itself a sharpening of the Helsinki Declaration, are stated. These three principles are the Principle of Utility, the Principle of Autonomy and the Principle of Justice. These are taken as voices of moral imperative. But although each has intuitive appeal, it can be shown that there are possible scenarios in which they give conflicting prescriptions. To achieve consistency, one must be subordinate to the others. The voice of utility is taken as subordinate to those of justice and autonomy and it is shown that given plausible assumptions about the level of poverty and education in the developing country targeted, the experiment is ruled morally wrong in the name of both justice and autonomy. Moreover, it is argued that no justification can be found for the inclusion of a placebo group, when strictly defined. By contrast, a ‘no- treatment’ control arm might be justified, but only when the demands of autonomy are satisfied, demands that are more stringent than they might appear. A utilitarian defence of the experiment is examined, namely that the would-be participants are in a no-loss situation, and it is shown that this defence is seriously flawed. Finally, it is concluded that there is no justification for amending the Declaration of Helsinki.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Ernst A. Singer (2004). The Necessity and the Value of Placebo. Science and Engineering Ethics 10 (1):51-56.
Paquita De Zulueta (2001). Randomised Placebo-Controlled Trials and HIV-Infected Pregnant Women in Developing Countries. Ethical Imperialism or Unethical Exploitation. Bioethics 15 (4):289–311.
Bozidar Vrhovac (2004). Placebo and the Helsinki Declaration — What to Do? Science and Engineering Ethics 10 (1):81-93.
Franklin G. Miller & Howard Brody (2002). What Makes Placebo-Controlled Trials Unethical? American Journal of Bioethics 2 (2):3 – 9.
Kjell Arne Johansson, Kirsten Bjerkreim Pedersen & Anna-Karin Andersson (2011). Hiv Testing of Pregnant Women: An Ethical Analysis. Developing World Bioethics 11 (3):109-119.
Reidar K. Lie (1998). Ethics of Placebo Controlled Trials in Developing Countries. Bioethics 12 (4):307–311.
James A. Anderson (2006). The Ethics and Science of Placebo-Controlled Trials: Assay Sensitivity and the Duhem-Quine Thesis. Journal of Medicine and Philosophy 31 (1):65 – 81.
David M. Kent, Mkaya Mwamburi, Richard A. Cash, Tracy L. Rabin & Michael L. Bennish (2003). Testing Therapies Less Effective Than the Best Current Standard: Ethical Beliefs in an International Sample of Researchers. American Journal of Bioethics 3 (2):28 – 33.
Hans-Jörg Ehni (2006). The Definition of Adequate Care in Externally Sponsored Clinical Trials: The Terminological Controversy About the Concept “Standard of Care”. Science and Engineering Ethics 12 (1):123-130.
Added to index2009-01-28
Total downloads63 ( #65,809 of 1,793,012 )
Recent downloads (6 months)49 ( #18,080 of 1,793,012 )
How can I increase my downloads?